<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR255">
 <label>255.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mimura</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Katoh</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Saldova</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>O'Flaherty</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Izumi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Mimura-Kimura</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy</article-title>
  <source>Protein Cell</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>47</fpage>
  <lpage>62</lpage>
  <pub-id pub-id-type="doi">10.1007/s13238-017-0433-3</pub-id>
  <?supplied-pmid 28597152?>
  <pub-id pub-id-type="pmid">28597152</pub-id>
 </element-citation>
</ref>
